Main Article Content

Muhammad Ayaz
Ikram Ullah
Nazia Imran
Maryam Iqbal
Sapna Quraish
Yusra Rasheed
Huma Rafiq
Ome Kalsoom Afridi
Sulaiman Shams


Silver, Nanoparticles, Liver, Mice, Characterization, Hepatic


Nanoparticles have intriguing properties that could assist the study of regenerative medicine. Silver Nanoparticles (AgNPs) have gained a lot of interest in a variety of industries, particularly pharmaceutics, agriculture, water purification, filtration of air, the textile industry, and as a catalyst in oxidation reactions. The aim of the current study was characterized the biosynthesized AgNPs and to evaluate their anti-hepatic activities through in-vivo studies. Biosynthesized AgNPs were characterized using various techniques including UV–VIS spectrophotometry, XRD, FESEM and FTIR analysis. The in-vivo anti-hepatic efficacy of AgNPs were assessed through morphological, biochemical and histological studies. For in-vivo studies, 12 Male Balb/C albino-mice were randomly divided into 3 groups (n = 4) including normal group, disease control group (Liver fibrotic model), and treatment group (liver fibrosis treated with AgNPs). Further, biochemistry markers including bilirubin level was assessed for all treatment groups. In CCl4-induced fibrotic mice, a considerable increased in glycogen was observed after treatment with AgNPs. Biochemical investigations revealed that all biochemical parameters for liver function such as bilrubin, was significantly lowered in AgNPs treated animals. Our findings indicate a preliminary multi-target efficacy for AgNPs against liver fibrotic and thus require further detailed investigation.

Abstract 23 | PDF Downloads 24


1. Ayaz, M., Iqba, M., Quraish S., Imran N., Rafiq, Huma., Khan, A., Shams, S. (2024). Preconditioning of stem cells with silver nanoparticles can reduce liver fibrosis in mice. Journal of population Therapeutics & Clinical Pharmacology. 31 (4): 289-299.
2. Boisseau, P. and Loubaton, B., 2011. Nanomedicine, nanotechnology in medicine. Comptes Rendus Physique , 12 (7):620-636.
3. Chaudhury, K., Kumar, V., Kandasamy, J. and RoyChoudhury, S., 2014. Regenerative nanomedicine: current perspectives and future directions. International Journal of Nanomedicine, 9:4153-64.
4. Fathi-Achachelouei, M., Knopf-Marques, H., Ribeiro da Silva, C.E., Barthès, J., Bat, E., Tezcaner, A. and Vrana, N.E., 2019. Use of nanoparticles in tissue engineering and regenerative medicine. Frontiers in bioengineering and biotechnology, 7:113-122.
5. Iqbal M., Shams S. Rafiq H , Khan M, Khan S, Khattak U. S., Afridi S. G., Bibi, F., Naseer M. (2023). Combinatorial Therapeutic Potential of Stem Cells and Benzimidazol Derivatives for the Reduction of Liver Fibrosis. Pharmaceuticals. 16(306): 1-24.
6. Khan, A, H., Ghufran, M., Shams, S., Jamal, A., Khan, A., Abdullah, Awan, Z. A. and Khan, M. I. 2023. Green synthesis of silver nanoparticles from plant Fagonia cretica and evaluating its anti-diabetic activity through indepth in-vitro and In-vivo analysis. Frontiers in Pharmacology.
7. Lavan, D.A., McGuire, T. and Langer, R., 2003. Small-scale systems for in vivo drug delivery. Nature biotechnology, 21(10), 1184-1191.
8. Nikalje, A.P., 2015. Nanotechnology and its applications in medicine. Med chem, 5(2), 81-89.
9. Pirtarighat, S., Ghannadnia, M. and Baghshahi, S., 2019. Green synthesis of silver nanoparticles using the plant extract of Salvia spinosa grown in vitro and their antibacterial activity assessment. Journal of Nanostructure in Chemistry, 9: 1-9.
10. Rafiq, H., Ayaz, M., Khan, A. H., Iqbal, M. Afridi., Shams, S. (2022). Therapeutic potential of stem cell and melatonin on the reduction of CCl4 -induced liver fibrosis in experimental mice mode. Brazilian Jouranl of Biology. 84, e253061.
11. Rajendran, R., Ganesan, N.I.T.H.Y.A., Balu, S.K., Alagar, S., Thandavamoorthy, P. and Thiruvengadam, D., 2015. Green synthesis, characterization, antimicrobial and cytotoxic effects of silver nanoparticles using Origanum heracleoticum L. leaf extract. Int J Pharmacy & Pharmaceutical Sci, 7(4): 288-93.
12. Rink, J.S., Plebanek, M.P., Tripathy, S. and Thaxton, C.S., 2013. Update on current and potential nanoparticle cancer therapies. Current opinion in oncology, 25(6):p.646.
13. Saini, R., Saini, S. and Sharma, S., 2010. Nanotechnology: the future medicine. Journal of cutaneous and aesthetic surgery, 3(1): 32-42.
14. Sayaf, K., Gabbia, D., Russo, F.P. and De Martin, S., 2022. The Role of Sex in Acute and Chronic Liver Damage. International Journal of Molecular Sciences, 23(18): 10654-67.
15. Shanmuganathan, R., MubarakAli, D., Prabakar, D., Muthukumar, H., Thajuddin, N., Kumar, S.S. and Pugazhendhi, A., 2018. An enhancement of antimicrobial efficacy of biogenic and ceftriaxone-conjugated silver nanoparticles: green approach. Environmental Science and Pollution Research, 25:10362-10370.
16. Tian, J., Wong, K.K., Ho, C.M., Lok, C.N., Yu, W.Y., Che, C.M., Chiu, J.F. and Tam, P.K., 2007. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem: Chemistry Enabling Drug Discovery, 2(1):129-136.
17. van Rijt, S. and Habibovic, P., 2017. Enhancing regenerative approaches with nanoparticles. Journal of the Royal Society Interface, 14(12): 93.
18. Waite, C.L. and Roth, C.M., 2012. Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Critical Reviews™ in Biomedical Engineering, 40(1). 1-12
19. Zhang, H., Jacob, J.A., Jiang, Z., Xu, S., Sun, K., Zhong, Z., Varadharaju, N. and Shanmugam, A., 2019. Hepatoprotective effect of silver nanoparticles synthesized using aqueous leaf extract of Rhizophora apiculata. International journal of nanomedicine. 3: 3517-3524.

Most read articles by the same author(s)